Boniva Injection
Overdosage & Contraindications
OVERDOSE
No cases of overdose were reported in premarketing studies with BONIVA Injection. Intravenous overdosage may result in hypocalcemia, hypophosphatemia, and hypomagnesemia. Clinically relevant reductions in serum levels of calcium, phosphorus, and magnesium should be corrected by intravenous administration of calcium gluconate, potassium or sodium phosphate, and magnesium sulfate, respectively.
Dialysis would not be beneficial unless it is administered within 2 hours following the overdose.
CONTRAINDICATIONS
- Known hypersensitivity to BONIVA Injection or to any of its excipients
- Uncorrected hypocalcemia (see PRECAUTIONS: General)
Brand Name: Boniva Injection
Generic Name: Ibandronate Sodium Injection
Generic Name: Ibandronate Sodium Injection
Next: Boniva Injection - Clinical Pharmacology »
« Previous: Boniva Injection - Warnings & Precautions
« Previous: Boniva Injection - Warnings & Precautions
Bookmark this page:
WebMD Resources
Calcium 101
An estimated 18 million Americans are at risk for osteoporosis. Taking the right calcium supplements now can help fight bone loss later. See more WebMD Videos »
Healthy Bones
Get tips and advances in treatment.
Boniva Injection
Related Drugs
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.